C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/04/2002	CN1382714A Polypeptide-microtubular bindin 190-65.89 and polynucleotide for coding it
12/04/2002	CN1382713A Polypeptide-human regulatory protein coupled receptor 38.28 and polynucleotide for coding it
12/04/2002	CN1382712A Polypeptide-human Golgi protein-74.36 and polynucleotide for coding it
12/04/2002	CN1382711A Polypeptide-kidney specific protein-54.78 and polynucleotide for coding it
12/04/2002	CN1382710A Polypeptide-human transporter-53.24 and polynucleotide for coding it
12/04/2002	CN1382709A Polypeptide-dole protein -50.16 and polynucleotide for coding it
12/04/2002	CN1382708A Polypeptide-liver period specific antigen-67.43 and polynucleotide for coding it
12/04/2002	CN1382707A Polypeptide-cytechrome P-450P-2-48.84 and polynucleotide for coding it
12/04/2002	CN1382706A Polypeptide-zinc finger protein 85-54.12 and polynucleotide for coding it
12/04/2002	CN1382705A Polypeptide-human ribosomal protein 9.02 and polynucleotide for coding it
12/04/2002	CN1382704A Polypeptide-beta-human microtubulin-11.44 and polynucleotide for coding it
12/04/2002	CN1382703A Polypeptide-protein-29.7 in adrenal medula ane polynucleotide for coding it
12/04/2002	CN1382702A Polypeptide-embryo development function associated protein -16.28 and polynucleotide for coding it
12/04/2002	CN1382701A Polypeptide-human epilepsia associated protein -11.77 and polynucleotide for coding it
12/04/2002	CN1382700A Polypeptide-corticotrophin releasing factor-12.87 and polynucleotide for coding it
12/04/2002	CN1382699A Polypeptide-nuclear triphosphoddenosine bindin-30.47 and polynucleotide for coding it
12/04/2002	CN1382698A Polypeptide-cell regulation factor-36.19 and polynucleotide for coding it
12/04/2002	CN1382697A Human testis development specific protein-28 gene coding protein
12/04/2002	CN1382696A Human testis development specific protein-25 gene coding protein
12/04/2002	CN1382695A Human testis development specific protein-22 gene coding protein
12/04/2002	CN1382694A Human testis development specific protein-17 gene coding protein
12/04/2002	CN1095499C Novel human thrombopoietin
12/03/2002	USRE37919 Linked to inducible bacterial promoter; sequences for human growth hormone, gene expression control, and enzymatic cleavage
12/03/2002	USRE37918 Nucleic acid derivatives
12/03/2002	USH2056 Model for von Hippel-Lindau disease
12/03/2002	US6489542 Plant expressing a fusion protein of an amino-terminal plastid transit peptide covalently linked to delta-endotoxin, localized to the plastids; plant insect resistance; higher level of expression, morphologically normal plants
12/03/2002	US6489535 Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype
12/03/2002	US6489463 Thymosin β-15 promoter and uses thereof
12/03/2002	US6489462 Dna sequence; highly expressed, constitutive promoter to express transgenes in fertile transgenic monocot and dicot plants
12/03/2002	US6489460 Cloned DNA encoding mammalian occludins
12/03/2002	US6489459 Hop=homolog of presenilin; isolated nucleic acid, vector and host cell; related to alzheimer's disease
12/03/2002	US6489456 Isolated nucleic acid of given sequence that encodes proteins related to the microtubule-associated protein secreted subfamily; use in drug development
12/03/2002	US6489454 Phagocytosis or engulfment; protein known as ced-6 acts as an adaptor molecule in a signal transduction pathway that mediates the engulfment of apoptotic cells; nucleotide sequences, vectors, host cells
12/03/2002	US6489453 Chandra: a TH1-specific gene
12/03/2002	US6489448 Antibody to a protein with thiol specific antioxidant (tsa) activity; vaccines
12/03/2002	US6489446 Self-aligning peptides modeled on human elastin and other fibrous proteins
12/03/2002	US6489445 Polypeptides which specifically bind to at least one human bone morphogenic protein (bmp) selected from bmp-5 and bmp-6
12/03/2002	US6489443 Carrying out heat treatment in glass vessel which has been rinsed out beforehand with detergent solution and then with distilled water or another detergent-free solvent
12/03/2002	US6489442 B-cell derived heptahelix receptor that is strongly expressed in brain and peripheral tissues; chemoattractant g-protein coupled receptor
12/03/2002	US6489441 Transcriptional co-repressor that interacts with nuclear hormone receptors
12/03/2002	US6489299 Lysine at position 91 is altered to another amino acid.
12/03/2002	US6489298 Contulakin-G, analogs thereof and uses thereof
12/03/2002	US6489297 Anti-neoplastic activity of novel vip peptide analogs using selected constrained amino acids such as diethylglycine, 1-aminocyclopentane carboxylic acid and di-n-propylglycine
12/03/2002	US6489295 Antagonists of intestinotrophic GLP-2 peptides
12/03/2002	US6489294 Truncated insulin-like growth factor binding protein-5 having mitogenic activity
12/03/2002	US6489293 Recombinant human erythropoietin with altered biological activity
12/03/2002	US6489290 Antiplatelet agent
12/03/2002	US6489289 Method for establishing a dosage plan for thrombin inhibitors
12/03/2002	US6489288 Treatment of polycystic ovarian disease
12/03/2002	US6489147 Gene for adenylate cyclase and its use
12/03/2002	US6489144 Culturing cells that overproduce double-stranded-rna-dependent kinase and treatment with inducer
12/03/2002	US6489143 Mutant plasminogen activator-inhibitor type 1 (PAI-1) proteins
12/03/2002	US6489142 Genes for retrovirus incorporated in recombined adenovirus defective for e1 or e4 regions
12/03/2002	US6489141 Codon replacement for higher translational efficiency
12/03/2002	US6489140 Preventing infestation of animals; gene expression and engineering
12/03/2002	US6489139 FabZ from Staphylococcus aureus
12/03/2002	US6489138 Diagnosing nervous system disorders; gene expression and engineering
12/03/2002	US6489137 For use in cancer diagnostics; detection of the loss and or alteration of wild-type hubub1 genes in tumor tissues
12/03/2002	US6489136 Cell proliferation related genes
12/03/2002	US6489126 To identify rheumatoid arthritis (ra), and also prepare reagents for the clinical diagnosis thereof
12/03/2002	US6489124 Neurotransmission by excitatory amino acids (eaas) such as glutamate is mediated via membrane-bound surface receptors. modulated by certain modulatory proteins. dna coding for a family of such modulatory proteins has now been isolated
12/03/2002	US6489123 Labelling and selection of molecules
12/03/2002	US6489122 Chlamydia pneumoniae antigenic polypeptides, which comprise polypeptide a containing a sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1, dnas encoding the antigenic polypeptides, or dnas complementary thereto;
12/03/2002	US6489118 Nucleotide sequences coding preferential peptides; for use in diagnosing and treatment of allergies
12/03/2002	US6489117 Enzymatic polypeptide for use in diagnosis of skin disorders
12/03/2002	US6489104 Screening for a dna encoding a protein that regulates the human p27.sup.kip1 promoter activity of a promoter dna, said promoter dna comprising at least a substantial portion of a fragment extending from nucleotide 2795 to nucleotide 3133 of
12/03/2002	US6489101 Breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast tumor protein, or a t cell that
12/03/2002	US6489099 Detection of DNA damaging agents
12/03/2002	US6488936 Glycoprotein d of herpes simplex type i and type ii
12/03/2002	US6488935 Dna coding for a peptide of a papilloma virus major capsid protein and a papilloma virus genome, respectively
12/03/2002	US6488933 Preparations for the treatment of T cell mediated diseases
12/03/2002	US6488932 Method for treating cancer by administering MAGE-derived peptides
12/03/2002	US6488931 Immunotherapy
12/03/2002	US6488929 Candida albicans phosphomannan complex as a vaccine
12/03/2002	US6488925 Macrophage inflammatory protein-4 (MIP-4) polypeptides
12/03/2002	CA2284077C Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection
12/03/2002	CA2254853C Compositions and methods for screening antimicrobials
12/03/2002	CA2213198C Gene therapy by anti-tgf-b agents
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
12/03/2002	CA2116478C Prolonged delivery of peptides
12/03/2002	CA2116120C Peptides having growth hormone releasing activity
12/03/2002	CA2107481C Osteoinductive protein mixtures and purification processes
12/03/2002	CA2073856C Glp-1 analogs useful for diabetes treatment
12/03/2002	CA2050910C Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
12/03/2002	CA2035474C Vaccine protecting against pig haemophilosis
12/03/2002	CA2030689C Barbiturate assay compositions and methods
12/03/2002	CA1341406C Crf analogs
12/03/2002	CA1341405C Methods of isolation and purification of g-csf
11/2002
11/30/2002	CA2384352A1 Novel polynucleotides from streptomyces avermitilis
11/29/2002	WO2001093899A1 PANCREATIC LANGERHANS β CELL PROLIFERATION PROMOTER AND APOPTOSIS INHIBITOR, AND SCREENING OF CANDIDATE COMPOUNDS FOR THE E DRUGS
11/29/2002	CA2410918A1 Agents for proliferating pancreatic beta-cells of the islets of langerhans, agents for suppressing apoptosis of said cells, and screening of candidate compounds for these agents
11/28/2002	WO2002095652A1 Crystallized human xenobiotic nuclear receptor pxr/sxr ligand binding domain polypeptide and screening methods employing same
11/28/2002	WO2002095414A1 Methods for screening using interleukin soluble trimolecular complex
11/28/2002	WO2002095410A1 Adherent entities and uses therefor
11/28/2002	WO2002095405A1 Membrane-resident steroid receptors and methods of use thereof
11/28/2002	WO2002095395A2 Benzophenone-linked crf and crf-like peptides for covalent labeling of corticotropin-releasing factor (crf) binding protein
11/28/2002	WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	WO2002095187A2 Methods of well treatment
11/28/2002	WO2002095099A1 Noncovalent sidewall functionalization of carbon nanotubes
11/28/2002	WO2002095076A2 Modified polypeptides having protease-resistance and/or protease-sensitivity

1 ... 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 ... 2916